Home >> Signaling Pathways >> Membrane Transporter/Ion Channel

Membrane Transporter/Ion Channel

Products for  Membrane Transporter/Ion Channel

  1. Cat.No. Product Name Information
  2. GC20029 L(-)-Borneol  L(-)-Borneol  Chemical Structure
  3. GC72133 &#181-Conotoxin-CnIIIC acetate µ-Conotoxin-CnIIIC acetate, a 22-residue conopeptide, is a potent antagonist of the voltage-gated NaV1.4 sodium channel with an IC50 of 1.3 nM acting at the neuromuscular junction. µ-Conotoxin-CnIIIC acetate  Chemical Structure
  4. GC45196 α-Bungarotoxin (trifluoroacetate salt)

    α-Bungarotoxin is a snake venom-derived toxin that irreversibly binds nicotinic acetylcholine receptors (Ki = ~2.5 μM in rat) present in skeletal muscle, blocking action of acetylcholine at the postsynaptic membrane and leading to paralysis.

    α-Bungarotoxin (trifluoroacetate salt)  Chemical Structure
  5. GC74347 α-Casozepine α-Casozepine is a bioactive peptide derived from the α protein S1 casein in milk and has an affinity for γ-aminobutyric acid (GABA) receptors in the brain. α-Casozepine  Chemical Structure
  6. GC49097 α-Conotoxin AuIB (trifluoroacetate salt)

    GCCSYPPCFATNPDC

    A conotoxin and an antagonist of α3β4 subunit-containing nAChRs α-Conotoxin AuIB (trifluoroacetate salt)  Chemical Structure
  7. GC49140 α-Conotoxin ImI (trifluoroacetate salt)

    α-CTx ImI, GCCSDPRCAWRC

    A conotoxin and an antagonist of α7 nAChRs α-Conotoxin ImI (trifluoroacetate salt)  Chemical Structure
  8. GC63269 α-Conotoxin PIA TFA α-Conotoxin PIA TFA  Chemical Structure
  9. GC63723 α-Conotoxin PnIA TFA α-Conotoxin PnIA TFA  Chemical Structure
  10. GC10873 α-Spinasterol

    Bessisterol, Hitodesterol

    TRPV1 antagonist α-Spinasterol  Chemical Structure
  11. GC70179 α7 Nicotinic receptor agonist-1

    Alpha-7 Nicotinic receptor agonist-1 (Preparation 5) is an alpha-7 nAChR agonist. It can be used for research on psychiatric disorders such as schizophrenia, mania or bipolar disorder, and anxiety disorders, as well as intellectual disabilities such as Alzheimer's disease, learning deficits, cognitive impairments, attention deficits, memory loss, Lewy body dementia and attention deficit hyperactivity disorder.

    α7 Nicotinic receptor agonist-1  Chemical Structure
  12. GC72246 αC-Conotoxin PrXA αC-Conotoxin PrXA is a paralytic peptide neurotoxin and a competitive nAChR antagonist, with IC50s of 1.8 nM (α1β1εδ, adult) and 3.0 nM (α1β1γδ, fetal), respectively. αC-Conotoxin PrXA  Chemical Structure
  13. GC48998 β-Defensin-1 (human) (trifluoroacetate salt)

    hBD-1

    An antimicrobial peptide β-Defensin-1 (human) (trifluoroacetate salt)  Chemical Structure
  14. GC70650 γ-Acetylenic GABA hydrochloride γ-Acetylenic GABA (GAG) hydrochloride is an irreversible inhibitor of GABA-transaminase. γ-Acetylenic GABA hydrochloride  Chemical Structure
  15. GC38010 γ-Aminobutyric acid γ-Aminobutyric acid  Chemical Structure
  16. GC64508 γ-Aminobutyric acid-d6

    γ-Aminobutyric acid-d6 (4-Aminobutyric acid-d6) is the deuterium labeled γ-Aminobutyric acid.

    γ-Aminobutyric acid-d6  Chemical Structure
  17. GC48313 γ-Lindane An insecticide and GABAA receptor antagonist γ-Lindane  Chemical Structure
  18. GC40635 δ2-Avermectin B1a δ2-Avermectin B1a is a degradation product formed by the reversible base-catalyzed isomerization of ivermectin B1a. δ2-Avermectin B1a  Chemical Structure
  19. GC15513 ω-Agatoxin IVA ω-Agatoxin IVA is a potent, selective P/Q type Ca2+ (Cav2.1) channel blocker with IC50s of 2 nM and 90 nM for P-type and Q-type Ca2+ channels, respectively. ω-Agatoxin IVA  Chemical Structure
  20. GC12608 ω-Agatoxin TK ω-Agatoxin TK, a peptidyl toxin of the venom of Agelenopsis aperta, is a potent and selective P/Q type Ca2+ channel blocker. ω-Agatoxin TK  Chemical Structure
  21. GC13886 ω-Conotoxin GVIA ω-Conotoxin GVIA is a cone snail toxin that selectively blocks N-type channels in neurons . ω-Conotoxin GVIA  Chemical Structure
  22. GC18070 ω-Conotoxin MVIIC wide spectrum blocker of N, P and Q type calcium channels ω-Conotoxin MVIIC  Chemical Structure
  23. GC31248 β-Amino Acid Imagabalin Hydrochloride (PD-0332334)

    PD-0332334

    β-Amino Acid Imagabalin Hydrochloride (PD-0332334) (PD-0332334) is a ligand for the α2δ subunit of the voltage-dependent calcium channel. β-Amino Acid Imagabalin Hydrochloride (PD-0332334)  Chemical Structure
  24. GC11449 β-CCB

    benzodiazepine receptor ligand

    β-CCB  Chemical Structure
  25. GC18033 γDGG γDGG is a competitive AMPA receptor blocker. γDGG  Chemical Structure
  26. GC45240 ω-Agatoxin IVA (trifluoroacetate salt)

    ω-Aga IVa, SNX-290

    ω-Agatoxin IVA is a natural peptide first isolated from the venom of funnel spiders. ω-Agatoxin IVA (trifluoroacetate salt)  Chemical Structure
  27. GC70188 ω-Agatoxin IVA TFA

    ω-Agatoxin IVA TFA is an effective selective blocker of P/Q-type Ca2+ (Cav2.1) channels, with IC50 values of 2 nM and 90 nM for P-type and Q-type Ca2+ channels, respectively. ω-Agatoxin IVA TFA (IC50, 30-225 nM) inhibits high potassium-induced glutamate release and calcium influx. It also blocks the release of serotonin and adrenaline induced by high potassium, without affecting L-type or N-type calcium channels.

    ω-Agatoxin IVA TFA  Chemical Structure
  28. GC45241 ω-Conotoxin GVIA (trifluoroacetate salt) ω-Conotoxin GVIA is a peptide originally isolated from the marine mollusk C. ω-Conotoxin GVIA (trifluoroacetate salt)  Chemical Structure
  29. GC62067 ω-Conotoxin GVIA TFA ω-Conotoxin GVIA TFA  Chemical Structure
  30. GA24016 ω-Conotoxin MVIIA ω-Conotoxin MVIIA (SNX-111), a peptide, is a potent and selective block of N-type calcium channels antagonist. ω-Conotoxin MVIIA  Chemical Structure
  31. GC45242 ω-Conotoxin MVIIC (trifluoroacetate salt)

    SNX-230

    ω-Conotoxin MVIIC is a peptide originally isolated from the marine mollusk C. ω-Conotoxin MVIIC (trifluoroacetate salt)  Chemical Structure
  32. GC64899 ω-Conotoxin MVIIC TFA ω-Conotoxin MVIIC TFA  Chemical Structure
  33. GC49296 τ-Fluvalinate

    tau-Fluvalinate

    A pyrethroid acaricide τ-Fluvalinate  Chemical Structure
  34. GC10237 (±)-1-(1,2-Diphenylethyl)piperidine maleate NMDA receptor antagonist (±)-1-(1,2-Diphenylethyl)piperidine maleate  Chemical Structure
  35. GC72625 (±)-Coniine hydrochloride (±)-Coniine hydrochloride (2-Propylpiperidine hydrochloride) is a potent nAChR agonist with an EC50 value of 0.3 mM. (±)-Coniine hydrochloride  Chemical Structure
  36. GC14410 (±)-Epibatidine

    CMI 545

    nicotinic agonist (±)-Epibatidine  Chemical Structure
  37. GC11138 (±)-HIP-A excitatory amino acid transporter (EAAT) blocker (±)-HIP-A  Chemical Structure
  38. GC13735 (±)-HIP-B

    excitatory amino acid transporter (EAAT) blocker

    (±)-HIP-B  Chemical Structure
  39. GC45985 (±)-Indoxacarb

    DPX-JW062, DPX-MP062

    A broad-spectrum insecticide (±)-Indoxacarb  Chemical Structure
  40. GC14834 (±)-Nipecotic acid

    (±)-Nipecotic Acid, (R,S)-Nipecotic Acid, 3-Piperidine Carboxylic Acid, DL-Piperidine 3-Carboxylic Acid

    GABA uptake inhibitor (±)-Nipecotic acid  Chemical Structure
  41. GC41676 (±)-Nornicotine

    DL-Nornicotine, (R,S)-Nornicotine

    (±)-Nornicotine is a metabolite of nicotine that acts as a neuronal nicotinic acetylcholine receptor (nAChR) agonist. (±)-Nornicotine  Chemical Structure
  42. GC49482 (±)-Nornicotine-d4

    DL-Nornicotine-d4, (R,S)-Nornicotine-d4

    An internal standard for the quantification of (±)-nornicotine (±)-Nornicotine-d4  Chemical Structure
  43. GC41677 (±)-SDZ-201 106

    DPI 201-106

    (±)-SDZ-201 106 (SDZ 201106) is a cardiotonic agent with a synergistic sarcolemmal and intracellular mechanism of action. (±)-SDZ-201 106  Chemical Structure
  44. GC11982 (±)-threo-3-Methylglutamic acid glutamate transport blocker (±)-threo-3-Methylglutamic acid  Chemical Structure
  45. GC46312 (±)-Verapamil-d3 (hydrochloride)

    (±)-Verapamil-d3 hydrochloride; CP-16533-1-d3 hydrochloride

    A neuropeptide with diverse biological activities (±)-Verapamil-d3 (hydrochloride)  Chemical Structure
  46. GC40466 (±)11(12)-EET

    (±)11,12-EpETrE

    (±)11(12)-EET is a fully racemic version of the R/S enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes.

    (±)11(12)-EET  Chemical Structure
  47. GC40434 (±)16-HETE

    (±)16-Hydroxyeicosatetraenoic Acid

    Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)16-HETE  Chemical Structure
  48. GC40438 (±)5(6)-EET

    (±)5,6EpETrE

    5(6)-EET is a fully racemic version of the enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes. (±)5(6)-EET  Chemical Structure
  49. GN10612 (+)- Praeruptorin C (+)- Praeruptorin C  Chemical Structure
  50. GC34954 (+)-Borneol

    D-Borneol, (1R)-(+)-Borneol, (+)-endo-Borneol

    (+)-Borneol  Chemical Structure
  51. GC30933 (+)-Kavain

    Kawain, NSC 112162

    An Analytical Reference Standard

    (+)-Kavain  Chemical Structure
  52. GC40808 (+)-Menthol

    D-Menthol

    (+)-Menthol is a monoterpene alcohol that has been found in Cannabis and has antifungal activity. (+)-Menthol  Chemical Structure
  53. GC16616 (+)-MK 801

    Dizocilpine maleate;Dizocilpine hydrogen maleate;(+)-MK 801;MK 801

    (+)-MK 801  Chemical Structure
  54. GC11025 (+)-MK 801 Maleate

    Dizocilpine Maleate

    (+)-MK 801 Maleate is a potent, selective and non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist (Ki = 30.5nM). (+)-MK 801 Maleate has been shown to be protective in various models of ischemia as well as to inhibit behavioral sensitization to certain psychostimulants. (+)-MK 801 Maleate  Chemical Structure
  55. GC32130 (+)-SJ733 (SJ000557733)

    SJ000557733

    (+)-SJ733 (SJ000557733) is an anti-malaria agent which can also inhibit Na+-ATPase PfATP4. (+)-SJ733 (SJ000557733)  Chemical Structure
  56. GC34959 (+)-Sparteine

    Pachycarpin, Pachycarpine

    (+)-Sparteine is a natural alkaloid acting as a ganglionic blocking agent. (+)-Sparteine  Chemical Structure
  57. GC38677 (-)-α-Pinene

    NSC 7727

    (-)-α-Pinene is a monoterpene and shows sleep enhancing property through a direct binding to GABAA-benzodiazepine (BZD) receptors by acting as a partial modulator at the BZD binding site. (-)-α-Pinene  Chemical Structure
  58. GC31084 (-)-(S)-B-973B (-)-(S)-B-973B  Chemical Structure
  59. GC10065 (-)-Bicuculline methiodide GABAA receptor antagonist (-)-Bicuculline methiodide  Chemical Structure
  60. GC16857 (-)-Bicuculline methobromide (-)-Bicuculline methobromide  Chemical Structure
  61. GC15636 (-)-Bicuculline methochloride (-)-Bicuculline methochloride  Chemical Structure
  62. GC13430 (-)-Blebbistatin

    (S)Blebbistatin

    (-)-Blebbistatin is one of the configurations of the racemic mixture (±)-Blebbistatin (Cat. No. GC12341) and is the active form. (-)-Blebbistatin is a cell-permeable inhibitor of non-muscle myosin II ATPase, which effectively inhibits multiple striated muscle myosins as well as vertebrate non-muscle myosins with IC50 values ranging from 0.5-5μM, and only slightly inhibits smooth muscle myosin (IC50=80μM) . (-)-Blebbistatin  Chemical Structure
  63. GC63940 (-)-Denudatin B (-)-Denudatin B is an antiplatelet agent. (-)-Denudatin B  Chemical Structure
  64. GC14157 (-)-Lobeline hydrochloride

    (-)-α-Lobeline, VUF 10751

    nicotinic receptor partial agonist (-)-Lobeline hydrochloride  Chemical Structure
  65. GC34951 (-)-Menthol

    L-Menthol, (1R,2S,5R)-(-)-Menthol, NSC 62788

    A monoterpene with diverse biological activities (-)-Menthol  Chemical Structure
  66. GC15270 (-)-MK 801

    (-)-Dizocilpine Maleate

    (-)-MK 801 ((-)-MK-801 maleate) is a less active (-)-enantiomer of Dizocilpine. (-)-MK 801  Chemical Structure
  67. GN10445 (-)-pareruptorin A (-)-pareruptorin A  Chemical Structure
  68. GC30889 (-)-Securinine

    NSC 107413, L-Securinine

    An alkaloid (-)-Securinine  Chemical Structure
  69. GC34952 (-)-Sparteine sulfate pentahydrate (-)-Sparteine sulfate pentahydrate  Chemical Structure
  70. GC14484 (-)-Xestospongin C

    XeC, Araguspongine E

    IP3-dependent Ca2+ release inhibitor

    (-)-Xestospongin C  Chemical Structure
  71. GC14044 (-)-[3R,4S]-Chromanol 293B (-)-[3R,4S]-Chromanol 293B is a potent and selective inhibitor of the slow component of delayed rectifier K+ current (IKs). (-)-[3R,4S]-Chromanol 293B  Chemical Structure
  72. GC64062 (1R,2R)-ML-SI3

    (1R,2R)-ML-SI3 is a potent inhibitor of both TRPML1 and TRPML2 (IC50 values of 1.6 and 2.3 μM) and a weak inhibitor (IC50 12.5 μM) of TRPML3.

    (1R,2R)-ML-SI3  Chemical Structure
  73. GC73042 (1S,2S)-ML-SI3

    (+)-trans-ML-SI3

    (1S,2S)-ML-SI3 is a trans-isomer of ML-SI3 that targets all three isoforms of TRPML. (1S,2S)-ML-SI3  Chemical Structure
  74. GC16915 (2R,3S)-Chlorpheg NMDA receptor antagonist (2R,3S)-Chlorpheg  Chemical Structure
  75. GC50536 (2R/S)-6-PNG

    (±)-6-PN

    CaV3.2 blocker; active in vivo (2R/S)-6-PNG  Chemical Structure
  76. GC66255 (E)-3,4,5-Trimethoxycinnamic acid

    TMCA

    (E)-3,4,5-Trimethoxycinnamic acid (TMCA) is a cinnamic acid substituted by multi-methoxy groups. (E)-3,4,5-Trimethoxycinnamic acid is an orally active and potent GABAA/BZ receptor agonist. (E)-3,4,5-Trimethoxycinnamic exhibits favourable binding affinity to 5-HT2C and 5-HT1A receptor, with IC50 values of 2.5 and 7.6 μM, respectively. (E)-3,4,5-Trimethoxycinnamic acid shows anticonvulsant and sedative activity. (E)-3,4,5-Trimethoxycinnamic acid can be used for the research of insomnia, headache and epilepsy. (E)-3,4,5-Trimethoxycinnamic acid  Chemical Structure
  77. GC62560 (E/Z)-Sivopixant

    (E/Z)-S-600918

    (E/Z)-Sivopixant ((E/Z)-S-600918) is a potent P2X3 receptor antagonist with an IC50 of 4 nM. (E/Z)-Sivopixant  Chemical Structure
  78. GC13895 (R)-(+)-Bay K 8644

    NI 105, R 4407

    L-type Ca2+-channel blocker (R)-(+)-Bay K 8644  Chemical Structure
  79. GC14085 (R)-(+)-HA-966 NMDA receptor antagonist/partial agonist (R)-(+)-HA-966  Chemical Structure
  80. GC40696 (R)-(+)-Pulegone

    NSC 15334, D-Pulegone

    (R)-(+)-Pulegone, the major chemical constituent of Calamintha nepeta (L. (R)-(+)-Pulegone  Chemical Structure
  81. GC10168 (R)-4-Carboxyphenylglycine NMDA receptor antagonist (R)-4-Carboxyphenylglycine  Chemical Structure
  82. GC11071 (R)-AMPA inactive enantiomer of AMPA (R)-AMPA  Chemical Structure
  83. GC14111 (R)-baclofen GABA receptor agonist (R)-baclofen  Chemical Structure
  84. GC34986 (R)-Baclofen hydrochloride

    (R)-Baclofen

    (R)-Baclofen hydrochloride (Arbaclofen hydrochloride) is a selective GABAB receptor agonist. (R)-Baclofen hydrochloride  Chemical Structure
  85. GC31665 (R)-BPO-27 (R)-BPO-27, the R enantiomer of BPO-27, is a potent, orally active and ATP-competitive CFTR?inhibitor with an?IC50 of 4 nM. (R)-BPO-27  Chemical Structure
  86. GC14236 (R)-CPP NMDA antagonist (R)-CPP  Chemical Structure
  87. GC69812 (R)-Elexacaftor

    (R)-VX-445

    (R)-Elexacaftor is the enantiomer of Elexacaftor (Compound 1) and comes from Compound 37 in patent WO2018107100A1. It is a corrector of cystic fibrosis transmembrane conductance regulator (CFTR), with an EC50 value of 0.29 uM for CFTR dF508.

    (R)-Elexacaftor  Chemical Structure
  88. GC62739 (R)-Funapide

    (R)-TV 45070; (R)-XEN402

    (R)-Funapide ((R)-TV 45070) is the less active R-enantiomer of Funapide. (R)-Funapide  Chemical Structure
  89. GC61847 (R)-Lanicemine (R)-Lanicemine ((R)-AZD6765) is the less active R-enantiomer of Lanicemine. (R)-Lanicemine  Chemical Structure
  90. GC66419 (R)-Lercanidipine-d3 hydrochloride (R)-lercanidipine D3 (hydrochloride) is a deuterium labeled (R)-Lercanidipine hydrochloride. (R)-Lercanidipine D3 (hydrochloride), the R-enantiomer of Lercanidipine, is a calcium channel blocker. (R)-Lercanidipine-d3 hydrochloride  Chemical Structure
  91. GC68475 (R)-Nicardipine

    (R)-YC-93 free base

    (R)-Nicardipine  Chemical Structure
  92. GC41719 (R)-nitro-Blebbistatin

    R(-)7Desmethyl8nitro Blebbistatin

    (R)-nitro-Blebbistatin is a more stable form of (+)-blebbistatin, which is the inactive form of (-)-blebbistatin. (R)-nitro-Blebbistatin  Chemical Structure
  93. GC67767 (R)-Olacaftor

    (R)-VX-440

    (R)-Olacaftor  Chemical Structure
  94. GC62513 (R)-Posenacaftor sodium

    (R)-PTI-801 sodium

    (R)-Posenacaftor (R)-PTI-801) sodium is the R enantiomer of Posenacaftor. (R)-Posenacaftor sodium  Chemical Structure
  95. GC69839 (R)-Tegoprazan

    (R)-CJ-12420; (R)-RQ-00000004

    (R)-Tegoprazan ((R)-CJ-12420; example 3) is a benzimidazole derivative and an effective inhibitor of gastric H+/K+-ATPase. Its IC50 for canine kidney Na+/K+-ATPase is 98 nM. (R)-Tegoprazan has potential in the research of gastrointestinal diseases.

    (R)-Tegoprazan  Chemical Structure
  96. GC70934 (R)-Vanzacaftor (R)-Vanzacaftor ((R)-VX-121) is a regulator of cystic fibrosis transmembrane conduction regulator (CFTR). (R)-Vanzacaftor  Chemical Structure
  97. GC60407 (R)-Verapamil D7 hydrochloride

    (R)-(+)-Verapamil D7 hydrochloride

    (R)-Verapamil D7 hydrochloride ((R)-(+)-Verapamil D7 hydrochloride) is a deuterium labeled (R)-Verapamil hydrochloride. (R)-Verapamil hydrochloride ((R)-(+)-Verapamil hydrochloride) is a P-Glycoprotein inhibitor. (R)-Verapamil hydrochloride blocks MRP1 mediated transport, resulting in chemosensitization of MRP1-overexpressing cells to anticancer drugs. (R)-Verapamil D7 hydrochloride  Chemical Structure
  98. GC60408 (R)-Verapamil hydrochloride (R)-Verapamil hydrochloride ((R)-(+)-Verapamil hydrochloride) is a P-Glycoprotein inhibitor. (R)-Verapamil hydrochloride blocks MRP1 mediated transport, resulting in chemosensitization of MRP1-overexpressing cells to anticancer drugs. (R)-Verapamil hydrochloride  Chemical Structure
  99. GC46344 (R,S)-AMPA (hydrate)

    αamino3hydroxy5methyl4Isoxazolepropionic Acid

    A neuropeptide with diverse biological activities (R,S)-AMPA (hydrate)  Chemical Structure
  100. GC70292 (Rac)-AMG8379 (Rac)-AMG8379 ((Rac)-AMG8380) is a racemate of AMG8379. (Rac)-AMG8379  Chemical Structure
  101. GC63511 (Rac)-CP-601927 hydrochloride (Rac)-CP-601927 hydrochloride is the racemate of CP-601927. (Rac)-CP-601927 hydrochloride  Chemical Structure

Items 1 to 100 of 2198 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction